<i>JAK3</i> <sup>A573V</sup> and <i>JAK3</i> <sup>M511I</sup> mutations in peripheral T-cell lymphoma mediating resistance to anti-PD-1 therapy through the STAT3/PD-L1 pathway Authors Xiaohong Han (ORCID: https://orcid.org/0000-0001-9190-0167) Zucheng Xie (ORCID: https://orcid.org/0000-0002-7910-9660) Ruyun Gao (ORCID: https://orcid.org/0009-0004-3683-8734) Le Tang (ORCID: https://orcid.org/0000-0002-5192-3329) Mengwei Yang (ORCID: https://orcid.org/0009-0000-0652-6212) Ning Lou (ORCID: https://orcid.org/0000-0003-0249-1192) Jiarui Yao (ORCID: https://orcid.org/0000-0002-9835-395X) Yuankai Shi (ORCID: https://orcid.org/0000-0002-8685-6744) Lei Zhang (ORCID: https://orcid.org/0009-0008-9783-092X) Institutions Chinese Academy of Medical Sciences & Peking Union Medical College (CN) Peking Union Medical College Hospital (CN) Publication Details Journal Journal for ImmunoTherapy of Cancer Published 2025-04-01 DOI https://doi.org/10.1136/jitc-2024-010783 Citations 8 Primary Topic Lymphoma Diagnosis and Treatment Type article Field-Weighted Citation Impact 11.77 Explore the Global Research Space Interactive Map